Scientific article

Current status of xenotransplantation and prospects for clinical application

Published inXenotransplantation, vol. 16, no. 5, p. 263-280
Publication date2009

Xenotransplantation is one promising approach to bridge the gap between available human cells, tissues, and organs and the needs of patients with diabetes or end-stage organ failure. Based on recent progress using genetically modified source pigs, improving results with conventional and experimental immunosuppression, and expanded understanding of residual physiologic hurdles, xenotransplantation appears likely to be evaluated in clinical trials in the near future for some select applications. This review offers a comprehensive overview of known mechanisms of xenograft injury, a contemporary assessment of preclinical progress and residual barriers, and our opinions regarding where breakthroughs are likely to occur.

  • Animals
  • Animals, Genetically Modified
  • Antigens/immunology
  • Blood Coagulation/physiology
  • Complement Activation/immunology
  • Graft Rejection
  • Graft Survival
  • Humans
  • Immune Tolerance/physiology
  • Immunosuppression
  • T-Lymphocytes/immunology
  • *Transplantation, Heterologous/pathology
Citation (ISO format)
PIERSON, Richard N 3rd et al. Current status of xenotransplantation and prospects for clinical application. In: Xenotransplantation, 2009, vol. 16, n° 5, p. 263–280. doi: 10.1111/j.1399-3089.2009.00534.x
Main files (1)
ISSN of the journal0908-665X

Technical informations

Creation04/23/2012 1:24:48 PM
First validation04/23/2012 1:24:48 PM
Update time03/14/2023 5:27:12 PM
Status update03/14/2023 5:27:12 PM
Last indexation02/12/2024 8:03:16 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack